Antimicrobial agents rationale and monitoring in an Italian hospital

Journal of Chemotherapy

Volumn 8, Issue 5, 1996, Pages 342-350

  De Lalla, F ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Antimicrobial agents usage; Cost containment; Drug cost analysis; Pharmacoeconomics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; UREIDOPENICILLIN DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG COST; DRUG USE; ECONOMICS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL PHARMACY; ITALY; PRESCRIPTION;

EID: 0029853889     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.5.342     Document Type: Article

References (19)

1. Fuchs VR. The health sector's share of the gross national product. Science 1990;247:534-538.
2. Pham SV, Draugalis JR. Quality of life. Economic analysis of drug therapies. Pharm World Sci 1993;15:50-55.
3. De Carli GF, Recchia G. Pharmacoeconomics and pharmacoeconomics research in Italy: situation and prospectives for the '90's; in Introduction to Pharmacoeconomics. OEMF (ed), Milano, 1993:179-191.
4. Kunin CM, Johansen KS, Worning AM, et al. Report of a symposium on use and abuse of antibiotics worldwide. Rev Infect Dis 1990;12:12-19.
5. Taylor D. Prescribing in Europe - forces for change. Br Med J 1992;304:239-242.
6. de Lalla F. Approccio economico al trattamento antibiotico delle infezioni in ambiente ospedaliero. Farm Ter 1993;X:36-44.
7. Halls GA. Antimicrobial practice. The management of infections and antibiotic practice: a European survey. J Antimicrob Chemother 1993;31:985-1000.
8. Fletcher CV, Metzier D, Borchardt-Phelps P, et al. Patterns of antibiotic use and expenditures during 7 years at a university hospital. Pharmacotherapy 1990;10:199-204.
9. O'Brien TF and the Members of Task Force 2. Resistance of bacteria to antibacterial agents: report of Task Force 2. Rev Infect Dis 1987;9:S244-S260.
10. Moellering RC. Interaction between antimicrobial consumption and selection of resistant bacterial strains. Scand J Infect Dis 1990;(suppl 70):18-24.
11. Kunin CM. The responsibility of the infectious disease community for the optimal use of antimicrobial agents. J Infect Dis 1985;151:388-396.
12. Kunin CM, Tupasi T, Craig W. Use of antibiotics. A brief exposition of the problem and some tentative solutions. Ann Intern Med 1973;79:555-560.
13. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 1988;157:869-876.
14. Martini N, Scroccaro G, Sala ML, et al. Antiinfectives consumption in a group of hospitals in three mediterranean countries: in Muller NF, Hekster YA (eds). Progress in Clinical Pharmacy. Proceedings of 18th European Symposium on Clinical Pharmacy. European Society of Clinical Pharmacy, 1990:220-221.
15. Janknegt R, Wijnands WJA, Caprasse M, et al. Antimicrobial drug use in hospital in the Netherlands, Germany and Belgium. Eur J Clin Microbiol Infect Dis 1993;12:832-838.
16. Wertheimer AI. The defined daily dose system (DDD) for drug utilization review. Hosp Pharm 1986;21:233-258.
17. Guidelines for DDD. WHO Collaborating Centre for Drug Statistics Methodology, Oslo and Norway and Nordic Council on Medicines, Uppsala, Oslo, Sweden, 1991.
18. Nordic Statistics on Medicines 1981-83: Part II. Nordic drug index with classification and defined daily doses. Uppsala 1985. NLN-Publikation No.15.
19. Bassetti D, Capri S. Criteri di scelta degli antibiotici iniettabili in ospedale: aspetti clinici ed economici. Antibioticoterapia Pratica 1993;4:29-50.